Literature DB >> 31081916

Teaching Opioid Tapering Through Guided Instruction.

Rebecca Claire Austin1, Carriedelle Wilson Fusco2, E Blake Fagan2, Evan Drake3, Josh Pacious3, Hallum Dickens3, Shelley L Galvin4, Courtenay Gilmore Wilson4.   

Abstract

BACKGROUND AND OBJECTIVES: Given the current opioid epidemic, national practice guidelines and many state laws are shifting the treatment paradigm for chronic, noncancer pain to a judicious use of opioids. This has prompted a need to teach family medicine residents how to appropriately taper opioids. We created a multifaceted approach to integrate teaching of opioid tapering into a family medicine curriculum with an emphasis on guided instruction. We assessed the degree to which this curriculum affected guideline-concordant opioid prescribing within the family medicine practice.
METHODS: A retrospective chart review of 707 patients on chronic opioid therapy (COT) for noncancer pain was conducted before and after the incorporation of a guided instruction experience to the residency curriculum. The primary outcomes included the number of patients on chronic opioids, the average morphine equivalent daily (MED) per patient, the percentage of patients on >50 MED or >90 MED, and the number of patients on concomitant benzodiazepines.
RESULTS: Of the original 707 patients, 188 tapered off COT. Of those remaining on COT, the average MED did not change (53.4±76.9 vs 58.5+89.1, P=0.053). The percentage of patients on >50 MED and >90 MED decreased significantly (30.6% vs 25.0%, P=0.001; 19.4% vs 14.0%, P=0.027). The total number of patients on concomitant benzodiazepine decreased from 212 to 131.
CONCLUSIONS: Providing opportunities for guided instruction with opioid tapering allowed for an increased concordance with national practice guidelines.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31081916     DOI: 10.22454/FamMed.2019.502509

Source DB:  PubMed          Journal:  Fam Med        ISSN: 0742-3225            Impact factor:   1.756


  3 in total

1.  Teaching safe and responsible opioid prescribing for chronic pain.

Authors:  Payam Sazegar
Journal:  Can Fam Physician       Date:  2020-04       Impact factor: 3.275

2. 

Authors:  Payam Sazegar
Journal:  Can Fam Physician       Date:  2020-04       Impact factor: 3.275

Review 3.  Evaluating opioid analgesic prescribing limits: A narrative review.

Authors:  Amy E Seitz; Karen A Janiszewski; Gery P Guy; Ryan T Tapscott; Emily B Einstein; Tamra E Meyer; Jessica Tierney; Judy Staffa; Christopher M Jones; Wilson M Compton
Journal:  Pharmacoepidemiol Drug Saf       Date:  2022-03-17       Impact factor: 2.732

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.